Location
United States, North America
Cheque size
$250K - $15M
Investment Stage
Seed
Series A
Series B
Series C
Focus Areas
AI
Health IT
Health & Hospital Services
BioTech
Cybersecurity
FinTech
About Investor
Johnny Hu is a principal at Menlo Ventures, where he invests in biotech and life science companies focused on novel therapeutics and new technologies that improve medical outcomes. He is active at Seed and Series A, with an investment range of $8M to $15M. Before Menlo, he invested at Longitude Capital and Omega Funds, and during his Harvard PhD he helped develop gene-editing technologies later licensed by Editas Medicine and Beam Therapeutics.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.